DR. MICHAEL J HOLTZMAN, MD
Osteopathic Medicine at Euclid Ave, Saint Louis, MO

License number
Missouri R2H44
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
660 S Euclid Ave, Saint Louis, MO 63110
Phone
(314) 362-8983
(314) 362-8987 (Fax)

Personal information

See more information about MICHAEL J HOLTZMAN at radaris.com
Name
Address
Phone
Michael Holtzman, age 75
14 Brentmoor Park, Saint Louis, MO 63105
(314) 452-0515
Michael J Holtzman, age 75
14 Brentmoor Park, Clayton, MO 63105
(314) 727-9412

Professional information

See more information about MICHAEL J HOLTZMAN at trustoria.com
Michael Jay Holtzman Photo 1
Michael Jay Holtzman, Saint Louis MO

Michael Jay Holtzman, Saint Louis MO

Specialties:
Internal Medicine, Pulmonary Disease, Cardiology, Cardiovascular Disease, Family Medicine, General Practice
Work:
Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
Education:
Northwestern University (1975)


Michael J Holtzman Photo 2
Dr. Michael J Holtzman, Saint Louis MO - MD (Doctor of Medicine)

Dr. Michael J Holtzman, Saint Louis MO - MD (Doctor of Medicine)

Specialties:
Pulmonology
Address:
WA Univ Schl Mdcn Plmnry Mdcn
660 S Euclid Ave SUITE 8052, Saint Louis 63110
(314) 454-8764 (Phone)
Certifications:
Internal Medicine, 1978, Pulmonary Disease, 1980
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
WA Univ Schl Mdcn Plmnry Mdcn
660 S Euclid Ave SUITE 8052, Saint Louis 63110
Barnes Jewish Hospital
1 Barnes Jewish Hospital Plz, Saint Louis 63110
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1975
Duke Med Ctr
U Calif


Michael Holtzman Photo 3
Compositions And Methods For Treatment Of Airway Hypersecretion

Compositions And Methods For Treatment Of Airway Hypersecretion

US Patent:
2007008, Apr 12, 2007
Filed:
Oct 10, 2006
Appl. No.:
11/545701
Inventors:
Michael Holtzman - Clayton MO, US
Assignee:
Washington University - St. Louis MO
International Classification:
A61K 48/00, A61K 39/395
US Classification:
514044000, 424145100
Abstract:
The invention relates generally to the field of treating pulmonary diseases. More specifically, the invention relates to the treatment of airway hypersecretion by the administration of an inhibitor of the epidermal growth factor receptor (EGFR) signaling pathway in combination with an inhibitor of the interleukin-13 (IL-13) signaling pathway, as well as compositions thereof.